GMP Synthesis of Bulk Drug Testing

Closed Solicitation Posted

This opportunity was awarded. See the award notice from , or the latest special notice from .

Solicitation number
75N95024R00058
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
North Bethesda, Maryland, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute on Drug Abuse (NIDA) is seeking proposals for "GMP Synthesis of Bulk Drug Substances" under RFP No. 75N95024R00058. NIDA is looking for contractors to provide a resource for the synthesis of bulk drug substances for use in preclinical toxicity studies and clinical trials. This RFP is being issued under full and open competition procedures. NIDA plans to award one indefinite delivery, indefinite quantity task order contract with a five-year period of performance. The contract will have a guaranteed minimum of $1,000 and a not-to-exceed maximum of $10,000,000. NIDA expects to award cost reimbursement and fixed-price task orders, and proposals are due by May 3, 2024.

This RFP does not have any set-aside designations, and the NAICS code is 541715. The place of performance is North Bethesda, MD, USA. NIDA has not provided any information regarding potential incumbents or current contractors. The RFP includes detailed instructions for technical, business, and cost proposals, as well as the evaluation criteria that will be used to make the award decision.

Notice text

The National Institute on Drug Abuse invites you to submit a proposal responding to the requirements of this RFP No. 75N95024R00058 for“GMP Synthesis of Bulk Drug Substances.”This RFP is released under FULL AND OPEN Competition Procedures. Please see the attached document for more details. 

Files

File Type Posted
D_RFP package.pdf PDF

Notice history

Notice Type Posted
GMP Synthesis of Bulk Drug Testing Award Award Notice
GMP Synthesis of Bulk Drug Testing Latest special notice Special Notice
This notice Solicitation
GMP Synthesis of Bulk Drug Testing Pre-Solicitation
GMP Synthesis of Bulk Drug Testing Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
Methylphenidate ER NAICS 325412 Medical Supply Chain No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity